Schroders, JP Morgan Asset Management and M&G Investments are among the firms with re-evaluated products.
Category: Research
Best and worst China equity funds of the decade
Active funds shone in a decade of poor performance for China indices and their trackers.
China Top Trumps – Hong Kong equities
This week FSA presents a quick comparison of two Hong Kong equity products: the BEA Hong Kong Growth Fund and the SSGA Tracker Fund of Hong Kong.
Best and worst bond funds of the decade
During a decade of US dollar strength and historically low interest rates, bond investors were paid to move down the credit curve.
Mutual Fund Top Trumps – Emerging Europe equities
This week FSA presents a quick comparison of two Emerging Europe equity products: the Templeton Eastern Europe Fund and the Pictet Emerging Europe Fund.
HEAD-TO-HEAD: BNY Mellon vs JP Morgan
FSA compares two global equity income products: the BNY Mellon Global Equity Fund and the JPM Global Dividend Fund.
Thai investors take profits from foreign investments
In 2019, Thai investors favoured domestic fund products, despite their lower returns compared with foreign investments, according to Morningstar.
Morningstar Asia fund review – January 2020
First State, Capital Group and Schroders are among the firms with re-evaluated products as Morningstar’s enhanced ratings framework ripples through the fund universe.
UBS forecasts $43bn in A-share inflows
Under-allocation to A-shares and the attraction of emerging markets could send RMB 300bn ($43.6bn) into A-shares in 2020.
HEAD-TO-HEAD: Blackrock vs JP Morgan AM
FSA compares two global emerging market equity products: the BGF Emerging Markets Fund and the JP Morgan Emerging Markets Equity Fund.
